Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Receivables - Other (2018 - 2025)

Historic Receivables - Other for Resmed (RSMDF) over the last 8 years, with Q4 2025 value amounting to $61.4 million.

  • Resmed's Receivables - Other rose 3060.68% to $61.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $61.4 million, marking a year-over-year increase of 3060.68%. This contributed to the annual value of $51.2 million for FY2025, which is 3402.56% up from last year.
  • Latest data reveals that Resmed reported Receivables - Other of $61.4 million as of Q4 2025, which was up 3060.68% from $51.1 million recorded in Q3 2025.
  • Resmed's Receivables - Other's 5-year high stood at $61.4 million during Q4 2025, with a 5-year trough of $10.9 million in Q2 2021.
  • Its 5-year average for Receivables - Other is $34.0 million, with a median of $32.4 million in 2023.
  • In the last 5 years, Resmed's Receivables - Other surged by 16913.21% in 2021 and then tumbled by 846.54% in 2022.
  • Quarter analysis of 5 years shows Resmed's Receivables - Other stood at $24.7 million in 2021, then dropped by 6.37% to $23.1 million in 2022, then surged by 49.62% to $34.6 million in 2023, then soared by 35.98% to $47.0 million in 2024, then surged by 30.61% to $61.4 million in 2025.
  • Its last three reported values are $61.4 million in Q4 2025, $51.1 million for Q3 2025, and $51.2 million during Q2 2025.